FCM
OXFD

Farallon Capital Management’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Farallon Capital Management’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-237,000
Closed -$4.59M – 102
2013
Q4 		$4.59M Buy
+237,000
New +$4.19M 0.1% 67

Other funds holding OXFD

CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
LPLP
Lansdowne Partners Limited Partnership London, United Kingdom $11.9B AUM 36% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Farallon Capital Management's OXFD Position: Q1 2014 in Review

Farallon Capital Management sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2014, closing a stake of 237,000 shares — an estimated $4.59M sold.

Farallon Capital Management first reported a position in OXFD in Q4 2013 and held it in 1 quarter. The position peaked at $4.59M in Q4 2013. 47 funds tracked by Wall St. Rank hold OXFD as of Q1 2014.

  • Farallon Capital Management reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2014 after selling out during the quarter.
  • Farallon Capital Management sold 237,000 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2014, an estimated $4.59M.
  • Farallon Capital Management first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2013 and held it in 1 quarter.
  • Farallon Capital Management's Oxford Immunotec Global PLC Ordinary Shares position peaked at $4.59M in Q4 2013.
  • 47 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2014.

Based on Farallon Capital Management's 13F filing for Q1 2014, filed 15 May 2014.